# Grok-4.1-Fast Review

**Role:** External referee review
**Model:** x-ai/grok-4.1-fast
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T14:07:15.256247
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 17476 in / 2563 out
**Response SHA256:** 05a1442005235fe8

---

## 1. IDENTIFICATION AND EMPIRICAL DESIGN (CRITICAL)

The identification relies on a continuous-treatment DiD (Eq. 1, Section 5.1): log(SCI_UK_f) × Post_t (Post=1 from 2016Q3) on log median price/m², with département FE (γ_f) and quarter-year FE (δ_t). This exploits cross-sectional variation in pre-existing UK social ties (total SCI from 96 French départements to 183 UK GADM2 regions, GADM2 vintage Oct 2021; Table 1 Panel A) for causal transmission of Brexit shock to French housing. Variation is credible: SCI Herfindahl=0.007 implies ~140 effective UK regions/département (Section 4.2, App. C); leave-one-UK-country-out stable (Fig. 4; Table 5). Timing coherent: data 2014Q1-2023Q4 (3,523 obs., 93 depts.; Table 1); Post aligns with referendum (June 23, 2016); split Post-Ref/Transition (Table 2 Col 2) shows effect pre-transition.

Key assumptions explicit: (i) exclusion (SCI_UK only affects outcomes via UK networks post-Brexit); (ii) parallel trends. Event study (Eq. 2, Fig. 2) shows flat pre-trends except τ=-4 outlier (β=-0.028, p=0.005); joint pre-trend Wald F=1.97 (p=0.038) marginally rejects (Section 6.3; App. B). Excluding outlier: p=0.093. Not fully clean—systematic pre-trend untestable without linear trend interaction reported pre-only (only full-sample trend β=0.005, p=0.15 in App. B).

Threats discussed: correlated shocks (German placebo), anticipation (minimal, markets priced Remain), COVID (controls in Table 7 Col 5), SCI measurement (Facebook-only, classical ME). Major threat: German placebo significant (Table 2 Col 4: β_DE=0.045, p=0.008), suggesting SCI_UK proxies general European openness (r(SCI_UK,SCI_DE)=0.42, R²=0.17; Table 3). Residualizing SCI_UK on SCI_DE/CH insignificant (Table 3 Cols 3-4: β=0.016, p~0.21); joint openness control preserves UK effect modestly (Col 2: β=0.023, p=0.061). SCI vintage post-Brexit (2021): potential bad control if Brexit altered networks (Section 8.2)—persistence assumed but untested (no pre-2016 SCI available). Swiss CHF placebo validates (Table 2 Col 6: β_CH=0.015, p<0.05). Overall credible for reduced-form network transmission but not UK-specific (composite effect).

## 2. INFERENCE AND STATISTICAL VALIDITY (CRITICAL)

Valid inference throughout. Main β=0.025 (SE=0.011 dept-clustered, t=2.19, p=0.031; Table 2 Col 1); all specs report SE, p-values, N=3,523, within-R², obs. consistent. 93 clusters sufficient. CI implicit in plots (Figs. 2-4,7). Permutation (2,000 draws, p=0.038; Fig. 3, Table 9)—sharp, robust to few clusters. Alternatives: 2-way cluster SE=0.011 (Table 7 Col 2); HC-robust SE=0.005 (Col 3, p<0.001)—all confirm significance. No TWFE bias (not staggered DiD; uniform Post). No RDD. Sample sizes coherent (e.g., houses N=3,519; Table 6). Passes.

## 3. ROBUSTNESS AND ALTERNATIVE EXPLANATIONS

Core result robust: probability vs. total SCI identical (Fig. 6, Table 7 Col 4); distance restrictions strengthen (Table 5); COVID controls (Table 7 Col 5). Placebos mixed: Swiss validates, German challenges (addressed but not eliminated). Falsification meaningful: permutation rejects random SCI assignment; LOO no single UK region/country drives (Fig. 4). Mechanism distinguished: reduced-form β but heterogeneity supports demand reallocation—houses β=0.035 (p=0.011) vs. apts β=0.006 (p=0.755; Table 6, hard for generic openness); Channel subsamples β=0.122 (p<0.001; Table 8); expat hotspots negative β=-0.105 (p=0.003, intra-France reallocation). Binscatter visualizes (Fig. 8). Limitations clear: European channel, SCI timing, no channel decomposition (Section 8). External validity bounded to network-mediated reallocation (Swiss generalizes). Strong but German placebo unresolved.

## 4. CONTRIBUTION AND LITERATURE POSITIONING

Clear differentiation: first cross-border causal SCI for demand reallocation (vs. Bailey et al. 2018/2021 trade; Burchardi 2013 intra-Germany; Mastrosavvas 2024 UK-internal politics). Extends Brexit lit (Born 2019 aggregate; Hassan 2024 firms; Dhingra 2017 regions—all UK-focused) with positive continental spillovers. Positions vs. shock geography (Autor 2013 labor; Mian 2014 housing). Coverage sufficient but missing: Goodman-Bacon 2021 decomposition (though not staggered); Adão et al. 2019 shift-share bias (analogous, SCI as "shares"). Add: Borusyak et al. 2022 (already cited); Autor et al. 2020 China shock networks; Peri/Taber 2024 SCI refinements. High contribution if ID strengthened.

## 5. RESULTS INTERPRETATION AND CLAIM CALIBRATION

Conclusions match: β=0.025 implies 0.7% Δlog price/SD(log SCI) (~10k SCI units; calibrated to 0.3-0.6% French GDP hit). Positive sign/heterogeneity (houses, Channel) supports reallocation over contagion; no overclaim (acknowledges composite effect). Policy proportional: redistributional, not aggregate boost. No contradictions: text aligns with tables (e.g., Table 2 Col 2 timing; no post-2021 jump). Pre-trend/placebo transparently flagged. Well-calibrated.

## 6. ACTIONABLE REVISION REQUESTS

### 1. Must-fix issues before acceptance
- **German placebo unresolved**: Significant β_DE violates exclusion (UK-specificity). Why: Undermines causal claim (Table 3 residual insignificant). Fix: Obtain pre-2016 SCI (if private access) or proxy (e.g., historical migration/Census); interact SCI_UK with UK-specific shock measure (e.g., ONS ITL3 GVA shocks × SCI weights, Section 4.4); report Sun-Abraham estimator for continuous-treatment DiD.
- **Pre-trends marginal rejection**: Joint p=0.038 (Fig. 2). Why: Parallel trends core assumption. Fix: Report pre-trend linear interaction (dept × time trend, pre-2016Q2 only); synthetic control/DiD weights; restrict to post-2015Q2 sample.
- **SCI post-treatment vintage**: 2021 data risks bad control. Why: Brexit may alter networks. Fix: Sensitivity to SCI × pre-Brexit dummy; correlate SCI with pre-2016 proxies (e.g., UK expat stocks from INSEE/Census).

### 2. High-value improvements
- **Alternative outcomes**: DVF-only (INSEE failed, Section 4.3). Why: Housing-specific; strengthens generalizability. Fix: Scrape/retrieve INSEE unemployment/firm creation (quarterly dept-level available via manual download); AirDNA/VNF for rentals.
- **Mechanism quantification**: Reduced-form only. Why: Claims demand reallocation but no flows. Fix: Merge DVF buyer nationality (if available post-2018); UK-France migration (Eurostat); Google Trends "buy house France" by dept.
- **Shift-share diagnostics**: Analogous to Bartik. Why: Herfindahl ok but formalize. Fix: Add Adão et al. 2019 eigenvalue; Borusyak et al. 2022 many shocks.

### 3. Optional polish
- **Bandwidth/event study**: τ=-4 outlier. Why: Visual clarity. Fix: Plot without outlier; report robust pre-trend tests.
- **External shocks**: COVID/2021 overlap. Why: Timing clean but quantify. Fix: Triple interaction (SCI_UK × Post × COVID).

## 7. OVERALL ASSESSMENT

**Key strengths**: Novel question (positive cross-border spillovers via networks); rich heterogeneity (property/geo, Tables 6/8); transparent limitations/placebos; robust inference (permutation, multiples SE); top-journal ready contribution if ID fixed.

**Critical weaknesses**: German placebo + residual insignificance erode UK-specificity; marginal pre-trends; post-Brexit SCI untested. Salvageable with data/design upgrades.

**Publishability after revision**: Strong potential for AER/QJE (networks + Brexit timely), but requires major ID strengthening.

DECISION: MAJOR REVISION